• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RAD6 碱基损伤耐受途径与复制叉解耦运作,且在 S 期之外具有功能。

The RAD6 DNA damage tolerance pathway operates uncoupled from the replication fork and is functional beyond S phase.

机构信息

Department of Molecular Cell Biology, Max Planck Institute of Biochemistry, Am Klopferspitz 18, 82152 Martinsried, Germany.

出版信息

Cell. 2010 Apr 16;141(2):255-67. doi: 10.1016/j.cell.2010.02.028.

DOI:10.1016/j.cell.2010.02.028
PMID:20403322
Abstract

Damaged DNA templates provide an obstacle to the replication fork and can cause genome instability. In eukaryotes, tolerance to damaged DNA is mediated largely by the RAD6 pathway involving ubiquitylation of the DNA polymerase processivity factor PCNA. Whereas monoubiquitylation of PCNA mediates error-prone translesion synthesis (TLS), polyubiquitylation triggers an error-free pathway. Both branches of this pathway are believed to occur in S phase in order to ensure replication completion. However, we found that limiting TLS or the error-free pathway to the G2/M phase of the cell-cycle efficiently promote lesion tolerance. Thus, our findings indicate that both branches of the DNA damage tolerance pathway operate effectively after chromosomal replication, outside S phase. We therefore propose that the RAD6 pathway acts on single-stranded gaps left behind newly restarted replication forks.

摘要

受损的 DNA 模板为复制叉提供了障碍,并可能导致基因组不稳定。在真核生物中,对受损 DNA 的容忍主要是通过 RAD6 途径介导的,该途径涉及 DNA 聚合酶持续因子 PCNA 的泛素化。虽然 PCNA 的单泛素化介导易错跨损伤合成(TLS),但多泛素化触发无错途径。人们认为这两个途径都发生在 S 期,以确保复制完成。然而,我们发现将 TLS 或无错途径限制在细胞周期的 G2/M 期,可有效地促进损伤容忍。因此,我们的发现表明,DNA 损伤容忍途径的两个分支在 S 期之外的染色体复制后都能有效地发挥作用。因此,我们提出 RAD6 途径作用于新重新启动的复制叉留下的单链缺口。

相似文献

1
The RAD6 DNA damage tolerance pathway operates uncoupled from the replication fork and is functional beyond S phase.RAD6 碱基损伤耐受途径与复制叉解耦运作,且在 S 期之外具有功能。
Cell. 2010 Apr 16;141(2):255-67. doi: 10.1016/j.cell.2010.02.028.
2
Error-free DNA-damage tolerance in Saccharomyces cerevisiae.酿酒酵母中无差错的 DNA 损伤容忍。
Mutat Res Rev Mutat Res. 2015 Apr-Jun;764:43-50. doi: 10.1016/j.mrrev.2015.02.001. Epub 2015 Feb 16.
3
Functional and physical interaction of yeast Mgs1 with PCNA: impact on RAD6-dependent DNA damage tolerance.酵母Mgs1与增殖细胞核抗原的功能及物理相互作用:对RAD6依赖的DNA损伤耐受性的影响
Mol Cell Biol. 2006 Jul;26(14):5509-17. doi: 10.1128/MCB.00307-06.
4
Regulation of double-stranded DNA gap repair by the RAD6 pathway.RAD6途径对双链DNA缺口修复的调控
DNA Repair (Amst). 2008 Nov 1;7(11):1893-906. doi: 10.1016/j.dnarep.2008.07.016. Epub 2008 Sep 11.
5
SUMO-modified PCNA recruits Srs2 to prevent recombination during S phase.小泛素样修饰物(SUMO)修饰的增殖细胞核抗原(PCNA)招募Srs2以防止S期发生重组。
Nature. 2005 Jul 21;436(7049):428-33. doi: 10.1038/nature03665. Epub 2005 Jun 1.
6
DNA bending facilitates the error-free DNA damage tolerance pathway and upholds genome integrity.DNA 弯曲有助于无差错的 DNA 损伤容忍途径,并维持基因组的完整性。
EMBO J. 2014 Feb 18;33(4):327-40. doi: 10.1002/embj.201387425. Epub 2014 Jan 28.
7
Defects in DNA ligase I trigger PCNA ubiquitylation at Lys 107.DNA 连接酶 I 的缺陷会触发 PCNA 在赖氨酸 107 处的泛素化。
Nat Cell Biol. 2010 Jan;12(1):74-9; sup pp 1-20. doi: 10.1038/ncb2007. Epub 2009 Dec 13.
8
PCNA Deubiquitylases Control DNA Damage Bypass at Replication Forks.PCNA 去泛素化酶控制复制叉处的 DNA 损伤绕过。
Cell Rep. 2019 Oct 29;29(5):1323-1335.e5. doi: 10.1016/j.celrep.2019.09.054.
9
The Rad5 helicase activity is dispensable for error-free DNA post-replication repair.Rad5解旋酶活性对于无差错的DNA复制后修复是可有可无的。
DNA Repair (Amst). 2014 Apr;16:74-83. doi: 10.1016/j.dnarep.2014.02.016. Epub 2014 Mar 13.
10
Control of spontaneous and damage-induced mutagenesis by SUMO and ubiquitin conjugation.通过SUMO和泛素缀合调控自发突变和损伤诱导的突变
Nature. 2003 Sep 11;425(6954):188-91. doi: 10.1038/nature01965.

引用本文的文献

1
Post-replicative lesion processing limits DNA damage-induced mutagenesis.复制后损伤处理限制DNA损伤诱导的诱变。
Nucleic Acids Res. 2025 Mar 20;53(6). doi: 10.1093/nar/gkaf198.
2
Translesion-synthesis-mediated bypass of DNA lesions occurs predominantly behind replication forks restarted by PrimPol.跨损伤合成介导的DNA损伤绕过主要发生在由PrimPol重新启动的复制叉之后。
Cell Rep. 2025 Mar 25;44(3):115360. doi: 10.1016/j.celrep.2025.115360. Epub 2025 Feb 26.
3
Ubiquitin protease Ubp1 cooperates with Ubp10 and Ubp12 to revert lysine-164 PCNA ubiquitylation at replication forks.
泛素蛋白酶Ubp1与Ubp10和Ubp12协同作用,以逆转复制叉处赖氨酸164位PCNA的泛素化。
Nucleic Acids Res. 2025 Feb 8;53(4). doi: 10.1093/nar/gkaf076.
4
Essential roles of Rad6 in conidial property, stress tolerance, and pathogenicity of .Rad6 在分生孢子特性、应激耐受性和致病性中的重要作用。
Virulence. 2024 Dec;15(1):2362748. doi: 10.1080/21505594.2024.2362748. Epub 2024 Jun 11.
5
EXO1 and DNA2-mediated ssDNA gap expansion is essential for ATR activation and to maintain viability in BRCA1-deficient cells.EXO1 和 DNA2 介导的单链 DNA 缺口扩展对于 ATR 的激活以及维持 BRCA1 缺陷细胞的存活至关重要。
Nucleic Acids Res. 2024 Jun 24;52(11):6376-6391. doi: 10.1093/nar/gkae317.
6
Role of Translesion DNA Synthesis in the Metabolism of Replication-associated Nascent Strand Gaps.跨损伤 DNA 合成在复制相关新生链缺口代谢中的作用。
J Mol Biol. 2024 Jan 1;436(1):168275. doi: 10.1016/j.jmb.2023.168275. Epub 2023 Sep 13.
7
A novel auxin-inducible degron system for rapid, cell cycle-specific targeted proteolysis.一种新型的生长素诱导降解结构域系统,用于快速、细胞周期特异性的靶向蛋白水解。
Cell Death Differ. 2023 Sep;30(9):2078-2091. doi: 10.1038/s41418-023-01191-4. Epub 2023 Aug 3.
8
Detection of endogenous translesion DNA synthesis in single mammalian cells.检测单个哺乳动物细胞中的内源性跨损伤 DNA 合成。
Cell Rep Methods. 2023 Jun 14;3(6):100501. doi: 10.1016/j.crmeth.2023.100501. eCollection 2023 Jun 26.
9
Timing of Chromosome DNA Integration throughout the Yeast Cell Cycle.酵母细胞周期中染色体 DNA 整合的时间。
Biomolecules. 2023 Mar 29;13(4):614. doi: 10.3390/biom13040614.
10
Roles of trans-lesion synthesis (TLS) DNA polymerases in tumorigenesis and cancer therapy.跨损伤合成(TLS)DNA聚合酶在肿瘤发生和癌症治疗中的作用。
NAR Cancer. 2023 Feb 6;5(1):zcad005. doi: 10.1093/narcan/zcad005. eCollection 2023 Mar.